Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
67,341,788
-
Total 13F shares
-
39,249,591
-
Share change
-
-2,011,023
-
Total reported value
-
$850,611,960
-
Put/Call ratio
-
284%
-
Price per share
-
$21.67
-
Number of holders
-
114
-
Value change
-
-$43,710,727
-
Number of buys
-
53
-
Number of sells
-
46
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) as of Q3 2020
As of 30 Sep 2020,
RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,249,591 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, JANUS HENDERSON GROUP PLC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, FEDERATED HERMES, INC., MPM ASSET MANAGEMENT LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
114
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.